Clinical Challenges in Lipid Disorders:

Name: Clinical Challenges in Lipid Disorders:
Price: 52.85 USD
Availability: InStock
ISBN: 9781846920295

ISBN-10: 1846920299

ISBN-13: 9781846920295

Edition: 2008

Authors: Peter P. Toth, D. A. Sica

List price: $99.95

30 day, 100% satisfaction guarantee!

Marketplace

2 new & used from $52.85

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

Aims to demonstrate to the reader that any clinical problem is likely to have several alternative solutions and that rarely do they present as the textbook example. This title reviews complex manifestations of lipid disorders. It presents alternative management strategies. It also presents treatment options for specific patient groups.

Book details

List price: $99.95
Copyright year: 2008
Publisher: Clinical Pub Serv
Binding: Cloth Text
Pages: 224
Size: 7.00" wide x 9.75" long x 1.00" tall
Weight: 2.046
Language: English



Editors and Contributors


Foreword


Preface


How well do various lipids and lipoprotein measures predict cardiovascular disease morbidity and mortality?


Framingham risk scoring or risk factor counting: which is more sensitive and how do I use this information to determine patient-specific lipid goals?


What is the metabolic syndrome, how do I treat it and is it a high-risk condition?


Should all patients admitted to the hospital with an acute coronary syndrome initiate statin therapy?


What are CAD risk equivalents and how did these clinical entities come to be so defined?


When should children and adolescents be screened for dyslipidemia and how should they be treated?


Management of dyslipidemia in women


In high and very high-risk patients, is it true that when it comes to LDL-c, lower is better and can a serum LDL-c be driven too low?


How should we approach to statin-treated patient with myalgia?


Pleiotropic effects of statins and their relevance to cardiovascular outcomes


An update on the 'rubber chicken' treatment of dyslipidemia: therapeutic lifestyle change and the alphabet soup of behavior modification


What is the best place for fibrate therapy in reducing cardiovascular risk?


Niacin for dyslipidemia management and atheroprevention: why, when and how?


Which dietary supplements have proven efficacy for impacting serum lipids and cardiovascular outcomes and are any vitamins harmful to the cardiovascular system?


Why do lipid-lowering agents affect serum transaminase levels, are these drugs toxic to the liver and can they precipitate liver failure?


Should we treat a low serum HDL-c and what specific lifestyle changes and drugs can be used to raise a low HDL-c?


What is familial hypercholesterolemia and how should it be treated?


Should plasma levels of lipoprotein(a) be measured? Guiding principles from bench to bedside


Clinical utilization of advanced lipid testing


Should we treat dyslipidemia in the elderly and is there an upper age limit to instituting lipid-lowering therapy?


List of abbreviations


Index